KR20190003010A - A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium - Google Patents

A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium Download PDF

Info

Publication number
KR20190003010A
KR20190003010A KR1020170083420A KR20170083420A KR20190003010A KR 20190003010 A KR20190003010 A KR 20190003010A KR 1020170083420 A KR1020170083420 A KR 1020170083420A KR 20170083420 A KR20170083420 A KR 20170083420A KR 20190003010 A KR20190003010 A KR 20190003010A
Authority
KR
South Korea
Prior art keywords
cosmetic composition
cold water
ethyl acetate
water extract
sanguisorba officinalis
Prior art date
Application number
KR1020170083420A
Other languages
Korean (ko)
Other versions
KR102133074B1 (en
Inventor
최창원
오성
김성대
노한별
Original Assignee
배재대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 배재대학교 산학협력단 filed Critical 배재대학교 산학협력단
Priority to KR1020170083420A priority Critical patent/KR102133074B1/en
Publication of KR20190003010A publication Critical patent/KR20190003010A/en
Application granted granted Critical
Publication of KR102133074B1 publication Critical patent/KR102133074B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Abstract

The present invention relates to a cosmetic composition containing a cold water extract of Sanguisorba officinalis L. or an ethyl acetate fraction thereof, wherein the cold water extract of Sanguisorba officinalis L. is obtained by extracting, with cold water, roots (sanguisorba roots) of Sanguisorba officinalis L. having specific anti-microbial activity against Propionibacterium acnes. The cosmetic composition is capable of preventing or improving acne and can be manufactured into compositions for cosmetics, soap, or cleansing agents.

Description

여드름 원인 세균에 대한 특이적 항균 활성을 가지는 오이풀 냉수추출물 또는 이의 분획물을 포함하는 화장료 조성물{A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium}[0001] The present invention relates to a cosmetic composition comprising an oily cold extract having a specific antibacterial activity against bacteria causing acne, or a fraction thereof. [0002]

본 발명은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지는 오이풀(Sanguisorba officinalis L.)의 뿌리(지유) 부분를 냉수(cold water)로 추출한 후 추출물 또는 이의 에틸아세테이트(ethyl acetate) 분획물을 포함하는 화장료 조성물에 관한 것이다. The present invention relates to a method for producing an extract of Sanguisorba officinalis L. by extracting the root portion of Sanguisorba officinalis L. having specific antibacterial activity with Propionibacterium acnes with cold water and then extracting the extract or its ethyl acetate fraction ≪ / RTI >

여드름(Acne vulgaris)은 피부의 탈피지 샘 단위(pilosebaceous unit)에 가장 흔하게 발생하는 염증성 질환으로서, 특히 사춘기 남성의 얼굴에 가장 흔하게 발생하고 간혹 등, 가슴 혹은 어깨에도 나타난다. 주원인은 피지선의 확장 및 면포(comedone) 형성과 함께 지나친 피지 (sebum)의 생산을 유도하는 남성호르몬 (androgen)의 효과에 기인한다. 다른 주원인은 비정상적 모낭 상피의 박리(피부 각질) 및 프로피오니박테리움 애크니스의 증식 때문이다. Acne vulgaris is the most common inflammatory disease of the pilosebaceous unit of the skin, most commonly on the face of adolescent men, and occasionally on the back, back, chest or shoulder. The main cause is the effect of the male hormone (androgen) which induces the production of excess sebum along with the expansion of sebaceous glands and the formation of comedones. Another major cause is the erosion of abnormal hair follicle epithelium (skin keratin) and the proliferation of propionibacterium acnes.

프로피오니박테리움 애크니스는 탈피지샘 단위에서 공생균으로 살아가는 혐기성(anaerobic), 그람양성(Gram positive), 간균(bacillus)이다. 비정상적 모낭 상피의 박리는 모낭에서 혐기성 조건을 일으켜 프로피오니박테리움 애크니스의 증식을 촉진한다. 또한, 프로피오니박테리움 애크니스는 지방분해효소(lipase) 및 주화성 인자를 분비하여 지나치게 분비된 피지 트리글리세리드(triglyceride)의 글리세롤 성분을 유리 지방산(free fatty acids)으로 물질대사 시킨다. 이러한 여분의 유리 지방산은 모낭 주위에 염증성 백혈구 생성을 촉진시킨다. 반면에 프로피오니박테리움 애크니스의 증식을 억제하면 면포의 파열을 최소화하여 여드름의 발달을 억제할 수 있다.Propionibacterium acnes are anaerobic, gram positive, bacillus, which live as symbiotic bacteria in the cleavage site. The exfoliation of abnormal hair follicle epithelium induces anaerobic conditions in the hair follicle and promotes the proliferation of propionibacterium acnes. In addition, Propionibacterium acnes secretes lipase and a chemotactic factor and metabolizes glycerol component of excessively secreted sebaceous triglyceride into free fatty acids. These extra free fatty acids promote the production of inflammatory leukocytes around the hair follicles. On the other hand, inhibition of the proliferation of propionibacterium acnes can minimize rupture of the cotton buds and inhibit the development of acne.

여드름 치료에 테트라사이클린(tetracycline), 에리쓰로마이신(erythromycin) 및 클린다마이신(clindamycin)과 같은 여러 가지 경구용 혹은 경피용 항생제가 사용되어 왔다. 이러한 광범위 스펙트럼을 가진 항생제의 장기간 사용은 캔디다 알비칸스(Candida albicans)의 과대성장 및 항생제 내성을 일으킬 수 있다. 또한, 항여드름 치료제로 알려진 과산화벤조일(benzoyl peroxide), 아젤라산(azelaic acid) 및 레티노산(retinoic acid)과 같은 경피용 화학제는 피부자극 및 접촉성피부염과 같은 부작용을 갖는 문제점이 있다. Several oral or transdermal antibiotics have been used to treat acne, such as tetracycline, erythromycin, and clindamycin. Prolonged use of these broad spectrum antibiotics can cause overgrowth of Candida albicans and resistance to antibiotics. In addition, transdermal chemical agents such as benzoyl peroxide, azelaic acid and retinoic acid, known as anti-acne treatments, have side effects such as skin irritation and contact dermatitis.

상기와 같은 문제점을 해결하기 위해 최근에 국제적으로 많은 항균성 식물이 보고되어 왔다. 그중에 일부는 여드름 치료에 대체 약물로 활용될 수 있다. 식물을 포함하여 현재 보고된 단일 식물의 표적 조직으로부터 획득한 추출물에서 프로피오니박테리움 애크니스에 대해 뚜렷한 항균활성을 나타낸 대다수의 추출물은 메탄올(특허문헌 0001, 0002, 0003 및 비특허문헌 0001, 0002, 0003, 0004), 에탄올(특허문헌 0004, 0005, 0006, 0007, 0008 및 비특허문헌 0005, 0006, 0007, 0008, 0009, 0010, 0011), 열수(특허문헌0009, 0010 및 비특허문헌 0012), 인산완충용액(특허문헌 0011), 아세톤(비특허문헌 0013), 기타 유기용매(비특허문헌 0014, 0015) 및 수증기증류법(특허문헌 0012 및 비특허문헌 0016)를 이용하였다. Recently, many antimicrobial plants have been reported internationally in order to solve the above problems. Some of these can be used as an alternative to acne treatment. The vast majority of extracts which showed pronounced antimicrobial activity against propionibacterium acnes in extracts obtained from the target tissues of presently reported single plants, including plants, are methanol (patent documents 0001, 0002, 0003 and non-patent documents 0001, 0002 , 0003, 0004), ethanol (Patent Document 0004, 0005, 0006, 0007, and Non-Patent Document 0005, 0006, 0007, 0009, 0010, 0011), hot water (Patent Document 0009, ), Phosphoric acid buffer solution (Patent Document 0011), acetone (non-patent document 0013), other organic solvents (Non-Patent Document 0014), and steam distillation method (Patent Document 0012 and Non-Patent Document 0016).

‘할랄(Halal)’ 시장은 국제시장 규모 중 가장 큰 시장 또한 성장하는 시장으로 주목받는 시장으로서, 무슬림들의 생활 수칙이며 이를 영위하기 위하여 필요한 상품이 할랄시장이다. 화장품의 경우 할랄 기준을 충족시키기 위해서는 식물체에서 유효 성분을 추출, 농축시키기 위하여 광범위하게 사용하는 에탄올(ethanol)을 전혀 사용할 수 없고 다가 알코올류 역시 동물 유래의 성분은 사용할 수 없다. The 'Halal' market is one of the largest markets in the international market. It is also a growing market. It is a Muslim lifestyle and a halal market. In the case of cosmetics, in order to satisfy the halal standard, ethanol widely used for extracting and concentrating an active ingredient in a plant can not be used at all, and polyhydric alcohols can not also be used as an animal-derived ingredient.

또한 발효 과정에서 사용하는 균주 역시 까다로운 기준에 따라 선택해서 사용해야 하며 발효 과정에서 생성되는 에탄올 역시 장애 요인이 될 수 있다. 따라서 다른 추출법과 비교하여 쉽게 유효성분을 추출할 수 있는 장점이 있는 냉수 및 열수를 이용한 추출방식이 유일한 대안이다. Also, the strains used in the fermentation process should be selected according to strict criteria and ethanol produced during the fermentation process may also be an obstacle. Therefore, the only alternative is the extraction method using cold water and hot water, which has the advantage of easily extracting the active ingredient compared with other extraction methods.

장미과(Rosacease)에 속한 다년생 식물인 오이풀(S. officinalis L.)은 국내를 포함한 극동 아시아 지역에 널리 분포하고 있다. 오이풀의 뿌리는 한방에서 지유(地楡)라는 생약재로 사용되고 있다(비특허문헌 0017). The perennial plant, S. officinalis L., belonging to Rosacease, is widely distributed in the Far East region including Korea. The roots of Oleaceae have been used as herbal medicines in oriental medicine (Non-Patent Document 0017).

지유는 한방에서 주로 지혈과 상처부위의 치료에 사용되어왔으며, 피부염, 점막염, 습진, 화상에 외용하는 것으로 알려져 있다(비특허문헌 0018). 지유에는 ziguglycoside I, II와 pomolic acid등이 함유되어 있고, 가지에는 quercetin과 kaempferol의 배당체와 ursolic acid 등 triterpenoid계 saponin 이 함유되어 있으며, 잎에는 vitamin C, 꽃에는 chrysanthemin, cyanin 등의 약리성분이 함유되어 있다 (비특허문헌 0019). Jiwoo has been mainly used in the treatment of hemostatic and wound areas in oriental medicine, and is known to externally use for dermatitis, mucositis, eczema, burns (Non-Patent Document 0018). It contains ziguglycoside I, II and pomolic acid. Branches contain quercetin and kaempferol glycosides and triterpenoid saponin such as ursolic acid. Vitamin C on leaf, pharyngeal component such as chrysanthemin and cyanin on flower (Non-Patent Document 0019).

상기와 같은 약리성분에 근거하여 오이풀로부터 면역억제 활성, 항돌연변이효과, 신경세포 손상 억제효과, 항산화효과, 과민성 알레르기 예방, 항암, 항균효과, 지혈작용 등의 연구가 보고되어 왔다(비특허문헌 0017, 0020, 0021, 0022; 0023, 0024, 0025, 0026, 0027). Based on the above-mentioned pharmacological components, there have been reported studies on immunosuppressive activity, antimutagenic effect, nerve cell damaging inhibitory effect, antioxidative effect, hypersensitivity allergy prevention, anticancer, antibacterial effect, and hemostatic action from Oyster (Non-Patent Document , 0020, 0021, 0022, 0024, 0024, 0026, 002, 0027).

오이풀 추출물에 대한 특허로는 충치를 유발하는 Streptococcus mutans 억제 구강청정제 조성물(특허문헌 0013), 패혈증을 유발하는 VHSV 및 IHNV에 대한 항바이러스 활성 조성물(특허문헌 0014), 피부부호 효과 화장료 조성물(특허문헌 0015), 당뇨 예방 및 개선용 조성물(특허문헌 0016), 리스테리 또는 살모넬라 유발 패혈증 예방 및 개선용 조성물(특허문헌 0017) 등이 있다.Patents for extracts of oat extracts include Streptococcus mutans-inhibiting oral detergent compositions (Patent Document 0013) that cause cavities, antiviral active compositions for VHSV and IHNV causing septicemia (Patent Document 0014), skin code effect cosmetic compositions , A composition for prevention and improvement of diabetes (Patent Document 0016), a composition for prevention and improvement of listeria or salmonella-induced sepsis (Patent Document 0017), and the like.

대한민국 공개특허공보 제10-2015-0000723호, 2015.01.05. 공개Korean Patent Publication No. 10-2015-0000723, 2015.01.05. open 대한민국 등록특허공보 제10-1507889호, 2015.04.07. 공고Korean Registered Patent No. 10-1507889, Apr. 20, 2015. Announcement 대한민국 공개특허공보 제10-2008-0044948호, 2008.05.22. 공개Korean Patent Publication No. 10-2008-0044948, May 22, 2008. open 대한민국 공개특허공보 특2002-0003313호, 2002.01.12. 공개Korean Patent Publication No. 2002-0003313, 2002.01.12. open 대한민국 공개특허공보 특2000-0019981호, 2000.04.15. 공개Korean Patent Publication No. 2000-0019981, Apr. 15, 2000. open 대한민국 공개특허공보 제10-2012-0086123호, 2012.08.22. 공개Korean Patent Publication No. 10-2012-0086123, Aug. 22, 2012. open 대한민국 공개특허공보 제10-2014-00992233호, 2014.08.11. 공개Korean Patent Laid-Open Publication No. 10-2014-00992233, 2014.08.11. open 대한민국 공개특허공보 제10-2004-0081533호, 2004.09.22. 공개Korean Patent Publication No. 10-2004-0081533, September 22, 2004. open 대한민국 공개특허공보 제10-0700911호, 2007.03.28. 공고Korean Patent Publication No. 10-0700911, March 28, 2007. Announcement 대한민국 등록특허공보 제10-0700912호, 2007.03.28. 공고Korean Registered Patent No. 10-0700912, March 28, 2007. Announcement 대한민국 공개특허공보 제10-2007-0110589호, 2007.11.20. 공개Korean Patent Publication No. 10-2007-0110589, 2007.11.20. open 대한민국 공개특허공보 특2003-0016818호, 2003.03.03. 공개Korean Patent Publication No. 2003-0016818, 2003.03.03. open 대한민국 공개특허공보 제10-2013-0113018호, 2013.10.15. 공개Korean Patent Publication No. 10-2013-0113018, Oct. 15, 2013. open 대한민국 공개특허공보 제10-2016-0150177호, 2016.12.29. 공개Korean Patent Publication No. 10-2016-0150177, December 29, 2016. open 대한민국 공개특허공보 제10-2009-0117199호, 2009.11.12. 공개Korean Patent Publication No. 10-2009-0117199, November 12, 2009. open 대한민국 공개특허공보 제10-2016-0102638호, 2016.08.31. 공개Korean Patent Publication No. 10-2016-0102638, Aug. 31, 2016. open 대한민국 공개특허공보 제10-2017-0055104호, 2017.05.19. 공개Korean Patent Publication No. 10-2017-0055104, Jul. open

Muddathir et al., J. Woos Sci. 2013, Vol. 59, pp. 426-431 Muddathir et al., J. Woos Sci. 2013, Vol. 59, pp. 426-431 Kim et al., J. Microbial. Biotechnol. 2010, Vol. 20, pp. 82-87 Kim et al., J. Microbial. Biotechnol. 2010, Vol. 20, pp. 82-87 Lim et al., J. Microbiol. 2007, Vol. 45, pp. 473-477 Lim et al., J. Microbiol. 2007, Vol. 45, pp. 473-477 Tsai et al., Food Chem. 2010, Vol. 119, pp. 964-968 Tsai et al., Food Chem. 2010, Vol. 119, pp. 964-968 Tangje Arung et al., Biodiversitas 2017, Vol. 18, pp. 321-325 Tangje Arung et al., Biodiversitas 2017, Vol. 18, pp. 321-325 Pothitirat et al., Pharm. Biol. 2010, Vol. 48, pp. 182-186 Pothitirat et al., Pharm. Biol. 2010, Vol. 48, pp. 182-186 Sharma and Lall, S. Afr. J. Sci. 2014, Vol. 110, Aer. # 2013-0293 Sharma and Lall, S. Afr. J. Sci. 2014, Vol. 110, Aer. # 2013-0293 Sharma et al., Phytother. Res. 2011, Vol. 25, pp. 517-521 Sharma et al., Phytother. Res. 2011, Vol. 25, pp. 517-521 Chomnawang et al., Fitoterapia 2007, Vol. 78, pp. 401-408 Chomnawang et al., Fitoterapia 2007, Vol. 78, pp. 401-408 Wang et al., J. Agric. Food Chem. 2013, Vol. 61, pp. 12274-12282 Wang et al., J. Agric. Food Chem. 2013, Vol. 61, pp. 12274-12282 Kumar et al., Trop. J. Pharm. Res. 2007, Vol. 6, pp. 717-723 Kumar et al., Trop. J. Pharm. Res. 2007, Vol. 6, pp. 717-723 Sathishkumar et al., J. Photocheml. PhotoBiol., B: Biology 2010, Vol. 20, pp. 82-87 Sathishkumar et al., J. Photocheml. Photo Biol., B: Biology 2010, Vol. 20, pp. 82-87 Vijayalakshimi et al., Int. J. PharmTech Res. 2011, Vol. 3, pp. 320-327  Vijayalakshimi et al., Int. J. PharmTech Res. 2011, Vol. 3, pp. 320-327 Shah et al., J. Med. Plants Res. 2015, Vol. 9, pp. 755-763  Shah et al., J. Med. Plants Res. 2015, Vol. 9, pp. 755-763 Pothitirat et al., Med. Princ. Pracy. 2010, Vol. 19, pp. 281-286 Pothitirat et al., Med. Princ. Pracy. 2010, Vol. 19, pp. 281-286 Qidwai et al., Int. J. Pharm. Sci. Res. 2016, Vol. 7, pp. 2917-2924 Qidwai et al., Int. J. Pharm. Sci. Res. 2016, Vol. 7, pp. 2917-2924 An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 244-250  An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 244-250 Son et al., J. Kor. Acad. Oral Health 2015, Vol. 28, pp. 97-104  Son et al., J. Kor. Acad. Oral Health 2015, Vol. 28, pp. 97-104 Lee et al., J. Korean Soc. Food Sci. Nutr. 2005, Vol. 34, pp. 1545-1552 Lee et al., J. Korean Soc. Food Sci. Nutr. 2005, Vol. 34, pp. 1545-1552 An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 131-145 An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 131-145 Ban et al., Kor. J. Med. Crop Sci. 2005, Vol. 13, pp. 219-226 Ban et al., Kor. J. Med. Crop Sci. 2005, Vol. 13, pp. 219-226 Goun et al., J. Ethnopharm. 2002, Vol. 81, pp. 337-342 Goun et al., J. Ethnopharm. 2002, Vol. 81, pp. 337-342 Hwang et al., J. Physiol. Pathol. Kor. Med. 2014, Vol. 28, pp. 499-505 Hwang et al., J. Physiol. Pathol. Kor. Med. 2014, Vol. 28, pp. 499-505 Kim et al., Nat. Prod. Sci. 2002, Vol. 8, pp. 177-182 Kim et al., Nat. Prod. Sci. 2002, Vol. 8, pp. 177-182 Kim et al., Kor. J. Food Cook. Sci. 2011, Vol. 27, pp. 15-26 Kim et al., Kor. J. Food Cook. Sci. 2011, Vol. 27, pp. 15-26 Park et al., Kor. J. Herb. 2012, Vol. 27, pp. 23-29 Park et al., Kor. J. Herb. 2012, Vol. 27, pp. 23-29 Park et al., Korean J. Food Preserv. 2012, Vol. 19, pp 744-750 Park et al., J. Food Preserv. 2012, Vol. 19, pp 744-750

본 발명의 목적은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지는 지유(오이풀의 뿌리)의 냉수 추출물 및 이의 에틸아세테이트(ethyl acetate) 분획물을 포함하는 화장료 조성물을 제공하는 것이다.It is an object of the present invention to provide a cosmetic composition comprising a cold water extract of a castor oil (root of oat) and an ethyl acetate fraction thereof having a specific antibacterial activity against Propionibacterium acnes.

상기 목적을 달성하기 위하여, 본 발명은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지는 지유(오이풀의 뿌리) 냉수 추출물 또는 이의 에틸아세테이트(ethyl acetate) 분획물을 포함하는 여드름 예방 또는 개선용 화장료 조성물을 제공한다. In order to achieve the above object, the present invention provides a method for preventing or ameliorating acne, which comprises a cold water extract of root oil (root of oat) or its ethyl acetate fraction having propionic acid, The present invention provides a cosmetic composition.

상기에 기술한 바와 같이, 본 발명에 따르면 지유의 냉수 추출물 또는 이의 분획물은 프로피오니박테리움 애크니스(Propionibacterium acnes) 특이적 항균 활성을 가지므로, 여드름의 예방 또는 개선에 효과가 있다. 따라서 이를 이용하여 화장료 조성물, 더 자세하게는 화장료, 비누 및 세정제 조성물 등으로 제품화 할 수 있다. As described above, according to the present invention, the cold water extract or the fraction thereof of the crude oil has an antibacterial activity specific to Propionibacterium acnes, and thus is effective for prevention or improvement of acne. Accordingly, the composition can be used as a cosmetic composition, more specifically, a cosmetic composition, a soap and a detergent composition.

도 1은 지유의 냉수추출물(CWE)로부터 활성 분획 분리과정의 흐름도이다.
도 2는 지유 냉수추출물(CWE) 및 냉수추출물의 에틸아세테이트 분획물(CWE-EA)의 여드름균(Propionibacterium acnes)에 대한 항균활성을 분석한 원판 평판배지 확산법(paper disc agar diffusion method)이다. 그림 (A)는 CWE 10 mg/disk 처리구(1), 무처리구(2), 증류수처리구(3)의 여드름균에 대한 억제환을 관찰한 사진이다. 그림 (B)는 증류수처리구(1) 및 CWE 1 mg/disk 처리구(2), 3 mg/disk 처리구(3), 5 mg/disk 처리구(4)의 여드름균에 대한 억제환을 관찰한 사진이다. 그림 (C)는 증류수처리구(1) 및 CWE-EA 1 mg/disk 처리구(2), 3 mg/disk 처리구(3), 5 mg/disk 처리구(4)의 여드름균에 대한 억제환을 관찰한 사진이다.
도 3은 지유의 냉수추출물(CWE)의 n-헥산(n-hexane), 에틸아세테이트(ethyl acetate), n-부탄올(n-butanol) 및 물 분획물을 원판 평판배지 확산법(paper disc agar diffusion method)에 의해 여드름균 억제를 비교 결과이다.
도 4는 지유의 냉수추출물(CWE)의 여드름균(Propionibacterium acnes)에 대한 최소억제농도(MIC) 및 최소살균농도(MBC)를 확인하기 위하여 고체배지에 콜로니 형성 유무를 확인한 결과이다.
도 5는 지유의 냉수추출물(CWE)의 에틸아세테이트(ethyl acetate) 분획물을 silica gel 60 glass plate에 점지하고 혼합용매 ethyl acetate, n-hexane, chloroform, acetic acid(40:30:30:2, v/v/v/v) 로 전개하고 UV 파장 254 nm (A), 366 nm (B) 및 황산 스프레이 발색법 (C)으로 분석한 것이다.
도 6은 지유의 냉수추출물(CWE)의 에틸아세테이트(ethyl acetate) 분획물을 TLC에서 전개한 후 획득하여 HPLC로 분석한 것이다. (1) 분리되지 않은 혼합 화합물, (2) caffeic acid, (3) ferulic acid, (4) quercetin, (5) kaempferol 이다.
1 is a flow chart of a process of separating active fractions from cold water extract (CWE) of crude oil.
2 is a paper disc agar diffusion method in which antimicrobial activity of CWE and ethyl acetate fraction (CWE-EA) of cold water extract against Propionibacterium acnes is analyzed. Figure (A) is a photograph of inhibitory rings against acne bacteria in CWE 10 mg / disk (1), untreated (2), and distilled water (3) Figure (B) is a photograph of the inhibitory ring against acne bacteria in the distilled water treatment (1) and CWE 1 mg / disk treatment (2), 3 mg / disk treatment (3) and 5 mg / . Figure (C) shows the inhibitory effect on the acne bacterium in the distilled water treatment (1) and CWE-EA 1 mg / disk treatment (2), 3 mg / disk treatment (3) and 5 mg / It is a photograph.
FIG. 3 is a graph showing the results of a paper disc agar diffusion method using n-hexane, ethyl acetate, n-butanol and water fractions of cold water extract (CWE) The results are compared with the inhibition of acne by.
FIG. 4 shows the results of confirming whether colonies were formed on a solid medium to confirm the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of the cold water extract (CWE) of crude oil on Propionibacterium acnes.
FIG. 5 is a graph showing the results obtained by pouring the ethyl acetate fraction of cold water extract (CWE) of crude oil onto a silica gel 60 glass plate and using a mixed solvent of ethyl acetate, n-hexane, chloroform, acetic acid (40: 30: 30: / v / v / v) and analyzed by UV wavelength 254 nm (A), 366 nm (B) and sulfuric acid spray coloring method (C).
FIG. 6 shows the ethyl acetate fraction of the cold water extract (CWE) of crude oil after being developed on TLC and analyzed by HPLC. (2) caffeic acid, (3) ferulic acid, (4) quercetin, and (5) kaempferol.

본 발명의 일실시예는 오이풀 (Sanguisorba officinalis)의 냉수추출물을 포함하는 여드름 개선용 화장료 조성물을 제공할 수 있다. One embodiment of the present invention can provide a cosmetic composition for improving acne comprising cold water extract of Sanguisorba officinalis.

오이풀은 장미과에 속하는 여러해살이풀이다. 한국, 일본, 유럽, 중국 만주 등지에 분포한다. 잎을 따서 부비면 오이냄새가 나서 오이풀이라 부른다. 한방에서는 오이풀의 뿌리를 지유라는 약재로 사용하고 있다. 오이풀 뿌리에는 17%타닌과 2.5%의 사포닌, Sanguisorbigenin이라는 배당체가 들어있고, 줄기와 잎에는 qurcetin과 Kaemferol 배당체, Ursolic acid 등 Triterpene류 물질이 들어있다. 지유(오이풀의 뿌리)는 한방에서는 몸의 열을 내려주고 출혈을 그치게 하는 효능이 있고, 해독작용이 있는 것으로 알려져 있다. 지유(오이풀의 뿌리)같은 경우 화상치료, 지혈작용, 구토억제 작용, 항균 작용 등에 효과가 있다. Oylum is a perennial plant belonging to Rosaceae. It is distributed in Korea, Japan, Europe and Manchu China. After picking the leaves, the smell of cucumbers is called oyula. In one room, the roots of Oylus are used as a medicinal herb. It contains 17% tannin, 2.5% saponin and Sanguisorbigenin, and the stem and leaf contain qurcetin, Kaemferol glycoside and Ursolic acid. Jili (Root of Oleaceae) in one room to lower the heat of the body and has the effect of stopping bleeding, is known to have detoxification. In the case of castor oil (roots of Oleacea), it is effective for burn treatment, hemostatic action, vomiting suppression action, antibacterial action and the like.

상기 오이풀의 냉수추출물은 1℃ 내지 20℃에서 12시간 내지 36시간 추출할 수 있으며, 바람직하게는 2℃ 내지 15℃에서 18시간 내지 30시간 추출할 수 있으며, 가장 바람직하게는 3℃ 내지 10℃에서 24시간 동안 추출할 수 있다.The cold water extract of the ores may be extracted at 1 to 20 ° C for 12 to 36 hours, preferably at 2 to 15 ° C for 18 to 30 hours, most preferably at 3 to 10 ° C For 24 hours.

본 발명에 있어서, 상기 화장료 조성물은 여드름균인 프로피오니박테리움 애크니스(Propionibacterium acnes)를 억제하는 것을 특징으로 할 수 있고, 가장 바람직하게는 KCTC3314 일 수 있다. In the present invention, the cosmetic composition may be characterized by inhibiting Propionibacterium acnes, which is an acne bacterium, and most preferably KCTC3314.

본 발명에 있어서, 상기 오이풀 (Sanguisorba officinalis)은 오이풀의 꽃, 잎, 줄기, 열매, 종자, 뿌리 및 전초를 포함하는 군으로부터 선택된 1 종 이상의 부위추출물인 것을 특징으로 할수 있고, 바람직하게는 오이풀의 뿌리 일 수 있다. In the present invention, the Sanguisorba officinalis may be at least one kind of region extract selected from the group consisting of flowers, leaves, stalks, fruits, seeds, roots and toppings of Oleaceae, It can be a root.

본 발명에 있어서, 상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제 함유 클렌징, 오일, 분말파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 및 스프레이를 포함하는 군으로부터 선택된 1종 이상의 제형을 갖는 것을 특징으로 할 수있으며, 바람직하게는 비누 또는 계면 활성제 함유 클렌징일 수 있다. In the present invention, the cosmetic composition may be a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a soap, a surfactant-containing cleansing oil, a powder foundation, an emulsion foundation, a wax foundation, , And may be a soap or a surfactant-containing cleansing agent.

본 발명에 있어서, 상기 오이풀 (Sanguisorba officinalis)의 냉수추출물은 1000 ㎍/mL 내지 1500 ㎍/mL 농도로 포함되는 것을 특징으로 할 수 있고, 바람직하게는 1250㎍/mL일 수 있다. In the present invention, the cold water extract of Sanguisorba officinalis may be contained at a concentration of 1000 μg / mL to 1500 μg / mL, preferably 1250 μg / mL.

본 발명에 있어서, 상기 오이풀 (Sanguisorba officinalis)의 냉수추출물부터 에틸아세테이트로 분획하여 획득한 에틸아세테이트 분획물을 포함하는 것을 특징으로 할 수 있다. In the present invention, it may be characterized by comprising an ethyl acetate fraction obtained by fractionating the cold water extract of Sanguisorba officinalis with ethyl acetate.

본 발명에 있어서, 상기 에틸아세테이트 분획물는 하이드록시시나믹 산(hydroxycinnamic acids) 및 플라보놀 (flavonols)으로 이루어진 군으로부터 선택되는 어느 하나 이상의 유효성분을 포함하는 것을 특징으로 할 수 있다. In the present invention, the ethyl acetate fraction may include any one or more active ingredients selected from the group consisting of hydroxycinnamic acids and flavonols.

본 발명에 있어서, 에틸아세테이트 분획물은 100 ㎍/mL 내지 200 ㎍/mL 농도로 포함하는 것을 특징으로 할 수 있으며, 바람직하게는 156 ㎍/mL으로 할 수 있다. In the present invention, the ethyl acetate fraction may be contained at a concentration of 100 μg / mL to 200 μg / mL, preferably 156 μg / mL.

이하, 실시예에 따라서 본 발명을 보다 구체적으로 설명하지만, 본 발명이 이하의 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the following examples.

지유의 냉수추출물 및 분획물Cold water extract and fraction

1. 지유의 냉수추출물(CWE) 제조1. Production of cold water extract (CWE)

오이풀 뿌리(지유)를 증류수로 세척하고 건조시킨 후 분쇄기로 잘게 분쇄하였다. 분쇄물 시료(50g)를 10배 중량의 4℃의 물을 가하고 24 시간 동안 추출한 후 와트만 종이 여과지(Whatman No. 2)로 여과한 후 그 여액을 65±2℃ 감압 농축하고 초저온냉동고에서 동결한 후 냉동건조기(freeze dryer)로 동결 건조하여 최종 추출물 0.2916g을 수득하였다. 지유 건물로부터 냉수 추출을 통한 수확량은 하기 표 1과 같다. Oylum root was washed with distilled water, dried and crushed finely with a grinder. 10 g of water at 4 ° C was added to the pulverized sample (50 g), and the mixture was extracted for 24 hours. The filtrate was filtered through Wattmann paper filter paper (Whatman No. 2), and the filtrate was concentrated under reduced pressure at 65 ± 2 ° C. And then lyophilized with a freeze dryer to obtain 0.2916 g of the final extract. The yields from cold-water extraction from cold storage are shown in Table 1 below.

지유로부터 냉수 추출을 통한 수확량 Yield from cold water extraction from castor oil 지유 건물중Building 냉수추출물(CWE)의 동결건조 수확량Freeze-dried yield of cold water extract (CWE) 50 g50 g 0.2916 g0.2916 g

2. 냉수추출물의 분획물(CWE fraction) 제조 2. Preparation of fraction of cold water extract (CWE fraction)

냉수추출물에 일정량의 물을 첨가한 후, 분액여두를 이용하여 극성이 다른 추출용매인 n-헥산, 에틸아세테이트, 부탄올 및 물을 차례대로 혼합하여 각 분획을 추출하였다. 먼저 분액여두에 n-헥산을 증류수와 동량으로 넣고, 잘 혼합한 후 수층과 추출용매의 두 층으로 나뉘도록 방치하였다. 추출용매를 분리하고 남은 여액을 다시 같은 방법으로 에틸아세테이트와 부탄올을 차례대로 넣어 각각 추출하였다. 이때 추출용매는 남은 여액과 같은 양으로 첨가하였다. 추출 및 분획 공정의 개략도를 [도 1]에 나타내었다. 실험결과, 순차적 분획물은 지유의 냉수추출물 50 g을 증류수 500 mL에 현탁시킨 후에 n-헥산(500 mL), 에틸아세테이트 (500 mL), n-부탄올 (500 mL) 그리고 증류수로 순차적으로 분획하여 분획물을 얻었다. After a certain amount of water was added to the cold water extract, each fraction was extracted by sequentially using n-hexane, ethyl acetate, butanol, and water as extraction solvents having different polarities using a separating funnel. First, n-hexane was added to the separatory funnel in the same amount as distilled water, mixed well, and left to separate into two layers, an aqueous layer and an extraction solvent. The extraction solvent was separated and the remaining filtrate was again extracted with ethyl acetate and butanol in the same manner. At this time, the extraction solvent was added in the same amount as the remaining filtrate. A schematic diagram of the extraction and fractionation process is shown in Fig. As a result, the sequential fractions were prepared by suspending 50 g of the cold water extract of the crude oil in 500 mL of distilled water and then sequentially fractionating the mixture with n-hexane (500 mL), ethyl acetate (500 mL), n-butanol ≪ / RTI >

식물 추출물 및 분획물의 항균 활성 실험Antimicrobial activity of plant extracts and fractions

그람음성균(2종) 및 그람양성균(3종)에 대한 항균 활성 측정은 원판 확산법(paper disk diffusion method), 최소억제농도(minimum inhibitoryconcentration, MIC) 및 최소살균농도(minimum bactericidal concentration, MBC)를 사용하여 평가하였다.The antimicrobial activity of Gram-negative bacteria (2 species) and Gram-positive bacteria (3 species) were measured using paper disk diffusion method, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) Respectively.

1. 대상 균주 및 배양조건1. Target strains and culture conditions

본 발명에 사용된 그람양성균인 프로피오니박테리움 애크니스(생물자원센터; KCTC3314)는 brain-heart infusion(BHI) 배지에서 혐기적 조건으로 2일 이상 배양하였으며, 리스테리아 모노사이토젠스(Listeria monocytogenes)와 포도상구균(Staphylococccus aureus)은 BHI 배지에서 호기적 조건으로 액체 배양하였다. 본 발명에 사용된 그람음성균인 대장균(Escherichia coli)과 비브리오장염균(Vibrio parahaemolyticus)는 Luria-Bertani(LB) 배지에서 액체배양하였다. 접종된 각 균주는 37℃, 200 rpm 조건에서 1~2일간 vernight) 진탕배양한 후 각 균의 성장과 용균은 Biochrom Libra S22 분광광도계(spectrophotometer)를 이용하여 O.D. 600nm에서 측정하였다.The Gram-positive bacteria Gram positive bacterium, Propionibacterium acnes (KCTC3314), were cultured in a brain-heart infusion (BHI) medium for 2 days or more under anaerobic conditions, and Listeria monocytogenes Staphylococcus aureus was cultured on BHI medium under aerobic conditions. The Gram-negative bacteria Escherichia coli and Vibrio parahaemolyticus used in the present invention were cultured in Luria-Bertani (LB) medium. Each strain was incubated at 37 ° C and 200 rpm for 1 to 2 days with shaking. Growth of each strain and lysis of bacteria were measured by a Biochrom Libra S22 spectrophotometer. Lt; / RTI >

2. 원판 평판배지 확산법(paper disc agar diffusion method)2. Paper disc agar diffusion method

배양한 균주를 일정한 농도(optical density 600 nm에서 흡광값 0.5)로 조절한 것을 멸균된 면봉을 이용하여 BHI 한천플레이트(agar plate) 혹은 LB 한천플레이트에 균일하게 도말하였다. 플레이트를 건조시킨 후, paper disc(Φ 6 mm, Adventec. USA)를 균주를 접종한 플레이트 표면위에 올려놓고 냉수추출물액 각각을 1, 3, 5 혹은 10 mg/disk씩 흡수시켰다. 시료가 처리된 플레이트를 48 시간 동안 37℃ 조건에서 배양한 후 디스크 주위의 생육 억제환(inhibition zone)의 크기로 항균 활성을 측정하였다. 이때 대조군으로는 항생제인 4종(ampicillin, kanamycin, spectinomycin, timentin)을 사용하였고, 처리 농도는 20 ?g/disc이다. 실험결과, 지유의 냉수추출물물 10 mg/disk 처리구에서 강력한 항여드름균 활성이 확인되었다 [도 2A 및 표 2]. 농도별 처리구에서도 1 mg/disk 처리구까지 우수한 항여드름균 활성이 확인되었다 [도 2B]. 그러나 다른 4종 박테리아에 대해서는 항균 활성이 전혀 관찰되지 않았다. 이 결과를 통해 지유의 냉수추출물은 프로피오니박테리움 애크니스에 대해 특이적 항균활성을 가지는 것으로 나타났으나, 다른 박테리아에 대해서는 항균활성이 없는 것으로 나타났다.The cultured strains were uniformly plated on a BHI agar plate or LB agar plate using a sterile cotton swab at a constant concentration (optical density at 600 nm, absorbance value 0.5). After drying the plates, paper discs (Φ 6 mm, Adventec. USA) were placed on the plates inoculated with the strains and each of the cold water extracts was absorbed at 1, 3, 5 or 10 mg / disc. The plate treated with the sample was incubated at 37 ° C for 48 hours, and the antimicrobial activity was measured to the extent of the inhibition zone around the disk. At this time, antibiotics (ampicillin, kanamycin, spectinomycin, timentin) were used as a control group and the treatment concentration was 20 g / disc. As a result, strong anti-acne activity was observed at 10 mg / disk of cold water extract of crude oil (Fig. 2A and Table 2). And excellent anti-acne activity was observed up to 1 mg / disk treatment even at the concentration-dependent treatment (Fig. 2B). However, no antibacterial activity was observed for the other four bacteria. These results indicate that the cold water extract of Jiu-Yi has a specific antimicrobial activity against Propionibacterium acnes, but has no antibacterial activity against other bacteria.

그람양성균 프로피오니박테리움 애크니스에 대한 항균 활성 Antibacterial activity against Gram positive bacterium, Propionibacterium acnes 시료(10 mg/disc)Samples (10 mg / disc) 생육억제환 크기(cm)Growth inhibition ring size (cm) 냉수추출물(CWE)Cold Water Extract (CWE) 3.2 x 3.03.2 x 3.0 ampicillinampicillin - kanamycinkanamycin 3.1 x 3.03.1 x 3.0 spectinomycinspectinomycin - timentintimentin -

또한, 지유의 냉수추출물로부터 획득한 에틸아세이트 분획물에서 우수한 항여드름균 활성이 관찰되었으나, 헥산, 부탄올 및 증류수 분획물에서는 미약하거나 관찰되지 않았다 [도 3]. 에틸아세이트 분획물의 농도별 처리 결과 1 mg/disk 처리구까지 우수한 항여드름균 활성이 확인되었다 [도 2C]. In addition, excellent anti-acne activity was observed in the ethyl acetate fraction obtained from the cold water extract of the crude oil, but it was weak or not observed in the hexane, butanol and distilled water fractions (Fig. 3). As a result of treatment with the concentration of ethyl acetate fraction, excellent anti-acne activity was confirmed up to 1 mg / disk treatment (Fig. 2C).

3. 여드름균에 대한 지유 냉수추출물(CWE) 및 에틸아세트 분획물(CWE-EA)의 최소억제농도(MIC) 및 최소살균농도(MBC)3. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of cold water extract (CWE) and ethylacetate fraction (CWE-EA)

프로피오니박테리움 애크니스를 BHI broth 배지를 함유한 시험관에서 24 시간 동안 37℃ 조건에서 배양하였다. 여기에 냉수추출물 및 에틸아세트 분획물을 2배 연속 희석법(two-fold dilution)으로 희석하여 시험관에 첨가하였다. 균희석액 및 시료를 접종한 시험관에서 48 시간 배양한 후 균의 가시적 생장을 저해하는 최소 농도를 MIC로 결정하였다. 하기 [표 3]에 나타낸 바와 같이, 프로피오니박테리움 애크니스에 대한 냉수추출물 및 에틸아세테이트 분획물의 MIC 값은 1250 μg/mL 및 156 μg/mL로 측정되었다. MIC로 선택된 농도보다 그 이상의 농도에 해당하는 시험관의 배양액 100 μL 씩 고체배지에 도말하여 균을 배양한 후 plate 상에서 관찰되는 콜로니(colony) 수를 직접 계수하였다. 이때 확인되어지는 콜로니 수가 100% 사멸되어지는 효과를 나타내는 추출물 처리농도를 MBC로 결정하고 하기 [표 3] 및 [도 4]와 같이 결정하였다. 하기 [표 3]에 나타낸 바와 같이, 프로피오니박테리움 애크니스에 대한 냉수추출물 및 에틸아세테이트 분획물의 MBC 값은 2500 μg/mL 및 312 μg/mL로 측정되었다.Propionibacterium acnes were cultured in a test tube containing BHI broth medium for 24 hours at 37 ° C. Here, the cold water extract and the ethylacetate fraction were diluted by two-fold dilution and added to the test tube. MIC was determined as the minimum concentration that inhibited the visible growth of the bacteria after incubation for 48 hours in a test tube inoculated with a bacterial dilution and a sample. As shown in Table 3 below, the MIC values of the cold water extract and ethylacetate fractions against propionibacterium acnes were determined to be 1250 and 156 μg / mL. The number of colonies observed on the plate was counted after culturing the bacteria on a solid medium of 100 μL of the culture medium of the test tube corresponding to a concentration higher than the concentration selected by MIC. MBC was used to determine the concentration of the extract to be treated at which 100% of the colonies were confirmed to be killed, and the concentration was determined as shown in [Table 3] and [Figure 4]. As shown in Table 3 below, the MBC values of the cold water extract and ethylacetate fractions against propionibacterium acnes were determined to be 2500 μg / mL and 312 μg / mL.

지유 냉수추출물과 추출물의 에틸아세테이트 분획물의 프로피오니박테리움 애크니스에 대한 최소억제농도 및 최소살균농도 The minimum inhibitory concentration and minimum germicidal concentration of the ethyl acetate fraction of the crude oil-extracted cold extract and the extract against the propionibacterium acnes 추출물extract MIC(㎍/mL)MIC ([mu] g / mL) MBC(㎍/mL)MBC (占 퐂 / mL) 냉수추출물(CWE)Cold Water Extract (CWE) 12501250 25002500 에틸아세테이트 분획물(CWE-EA)The ethyl acetate fraction (CWE-EA) 156156 312312

항여드름균 활성을 가진 에틸아세티이트 분획물의 성분 분석Analysis of Components of Ethyl Acetate Fractions Having Antimicrobial Activity

1. 박층 크로마토그래피(Thin layer chromatography; TLC)1. Thin layer chromatography (TLC)

항여드름균 활성을 가진 에틸아세티이트 분획물을 silica gel 60 glass plate(20 x 20 cm, Merck, DarDarmstadt, Germany)를 이용하여 에틸아세테이트/헥산/클로로포름/ 초산(40:30:30:2, v/v/v/v) 혼합 용매로 하여 전개하고 UV 램프(254 nm 및 366 nm 파장) 및 황산 스프레이 발색법으로 에틸아세테이드 분획물과 표준물질(caffeic acid, ferulic acid, quercetin, kaempferol)과의 Rf 값을 비교하여 분석하였다. 상기의 방법으로 실험한 결과 표준물질인 caffeic acid, ferulic acid, quercetin, kaempferol Rf 값과 비슷한 band를 확인할 수 있었다 [도 5.]The ethyl acetate fraction with antimicrobial activity was extracted with ethyl acetate / hexane / chloroform / acetic acid (40: 30: 30: 2, v / v) using a silica gel 60 glass plate (20 x 20 cm, Merck, DarDarmstadt, Germany) / v / v / v) mixed solvent, and the ratio of ethyl acetate fraction and standard substances (caffeic acid, ferulic acid, quercetin, kaempferol) was measured by UV lamp (254 nm and 366 nm wavelength) Rf values were compared and analyzed. As a result of the above experiment, it was confirmed that bands similar to the Rf values of caffeic acid, ferulic acid, quercetin and kaempferol were observed [Fig. 5.]

2. High performance liquid chromatography(HPLC)2. High performance liquid chromatography (HPLC)

에틸아세테이트 분획물을 methanol에 녹이고 여과(0.45 μm filter)하여 HPLC(1260 Infinity Quaternary LCSystem, Agilent Technologies, Waldbronn, Germany)에 ZORBAX Eclipse Plus C18 column(4.6×150 mm, 5 μm, Agilent Technologies, Lawrence, KS, USA)을 사용하여 254 nm에서 분석하였다. Injection volume은 10 μL, 이동상은 용매 A(2% acetic acid in 30% methanol)와 B(2% acetic acid in 50% acetonitrile)를 유속 1mL/min으로 A액과 B액의 비율 100:0(v/v)에서 70분까지 0:100(v/v)의 비율로 농도기울기법으로 분석하였다. 함량 측정은 표품 caffeic acid, ferulic acid, quercetin, kaempferol을 이용하여 작성한 검량선의 회귀식에서 구하였다. 상기의 방법으로 실험한 결과 역상 HPLC 방법으로 청미래의 분획물 중에서 표준물질과의 retention time을 비교하여 2종의 hydroxycinnamic acids(caffeic acid, ferulic acid) 및 2종의 flavonols(quercetin, kaempferol)을 확인하였다 [도 6]. 지유 냉수추출물의 에틸아세테이트 분획물 중 caffeic acid, ferulic acid, quercetin, kaempferol 등을 포함하여 여러 미지 물질이 검출되었으며 그중 ferulic acid 함량이 가장 높았다. The ethyl acetate fraction was dissolved in methanol, filtered (0.45 μm filter) and loaded on a ZORBAX Eclipse Plus C18 column (4.6 × 150 mm, 5 μm, Agilent Technologies, Lawrence, KS) using HPLC (1260 Infinity Quaternary LCSystem, Agilent Technologies, Waldbronn, Germany) USA) at 254 nm. Injection volume was 10 μL and the mobile phase was solvent A (2% acetic acid in 30% methanol) and B (2% acetic acid in 50% acetonitrile) at a flow rate of 1 mL / / v) to 70 minutes at a ratio of 0: 100 (v / v). The content was determined by the regression equation of the calibration curve prepared using the product caffeic acid, ferulic acid, quercetin and kaempferol. As a result of the above tests, two kinds of hydroxycinnamic acids (caffeic acid, ferulic acid) and two kinds of flavonols (quercetin and kaempferol) were identified by the reversed phase HPLC method by comparing the retention time with the standard substance in the fractions of Cheongmaeae 6]. Among the ethylacetate fractions of the crude oil extracts, various unknown substances including caffeic acid, ferulic acid, quercetin and kaempferol were detected, and ferulic acid content was the highest.

Claims (9)

오이풀 (Sanguisorba officinalis)의 냉수추출물을 포함하는 여드름 개선용 화장료 조성물. A cosmetic composition for improving acne comprising cold water extract of Sanguisorba officinalis. 제 1항에 있어서, 상기 화장료 조성물은 여드름균인 프로피오니박테리움 애크니스(Propionibacterium acnes)를 억제하는 것을 특징으로 하는 여드름 개선용 화장료 조성물.The cosmetic composition for improving acne according to claim 1, wherein the cosmetic composition inhibits Propionibacterium acnes, an acne bacterium. 제 1항에 있어서, 상기 오이풀 (Sanguisorba officinalis)은 오이풀의 꽃, 잎, 줄기, 열매, 종자, 뿌리 및 전초를 포함하는 군으로부터 선택된 1 종 이상의 부위추출물인 것을 특징으로 하는 여드름 개선용 화장료 조성물. [Claim 7] The cosmetic composition for improving acne according to claim 1, wherein the Sanguisorba officinalis is at least one region extract selected from the group consisting of flowers, leaves, stems, fruits, seeds, roots and outposts of Olefins. 제 1 항에 있어서, 상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제 함유 클렌징, 오일, 분말파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 및 스프레이를 포함하는 군으로부터 선택된 1종 이상의 제형을 갖는 것을 특징으로 하는 여드름 개선용 화장료 조성물. The cosmetic composition of claim 1, wherein the cosmetic composition comprises a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, Wherein the cosmetic composition has at least one formulation selected from the group consisting of: 제 1항에 있어서, 상기 오이풀 (Sanguisorba officinalis)의 냉수추출물은 1000 ㎍/mL 내지 1500 ㎍/mL 농도로 포함되는 것을 특징으로 하는, 여드름 개선용 화장료 조성물. The cosmetic composition for improving acne according to claim 1, wherein the cold water extract of Sanguisorba officinalis is contained at a concentration of 1000 μg / mL to 1500 μg / mL. 제 1항에 있어서, 상기 오이풀 (Sanguisorba officinalis)의 냉수추출물부터 에틸아세테이트로 분획하여 획득한 에틸아세테이트 분획물을 포함하는 것을 특징으로하는, 여드름 개선용 화장료 조성물. The cosmetic composition for improving acne according to claim 1, which comprises an ethyl acetate fraction obtained by fractionating the cold water extract of Sanguisorba officinalis with ethyl acetate. 제 6항에 있어서, 상기 에틸아세테이트 분획물는 하이드록시시나믹 산(hydroxycinnamic acids) 및 플라보놀 (flavonols)으로 이루어진 군으로부터 선택되는 어느 하나 이상의 유효성분을 포함하는 것을 특징으로 하는, 여드름 개선용 화장료 조성물.7. The cosmetic composition for improving acne according to claim 6, wherein the ethyl acetate fraction comprises at least one active ingredient selected from the group consisting of hydroxycinnamic acids and flavonols. 제 6항에 있어서, 상기 에틸아세테이트 분획물은 100 ㎍/mL 내지 200 ㎍/mL 농도로 포함하는 것을 특징으로 하는, 여드름 개선용 화장료 조성물.7. The cosmetic composition for improving acne according to claim 6, wherein the ethyl acetate fraction is contained at a concentration of 100 mu g / mL to 200 mu g / mL. 오이풀 (Sanguisorba officinalis)의 냉수추출물 또는 이의 분획물을 포함하는 의약외품.
Quasi-drugs including cold water extracts of Sanguisorba officinalis or fractions thereof.
KR1020170083420A 2017-06-30 2017-06-30 A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium KR102133074B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170083420A KR102133074B1 (en) 2017-06-30 2017-06-30 A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170083420A KR102133074B1 (en) 2017-06-30 2017-06-30 A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium

Publications (2)

Publication Number Publication Date
KR20190003010A true KR20190003010A (en) 2019-01-09
KR102133074B1 KR102133074B1 (en) 2020-07-10

Family

ID=65017477

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170083420A KR102133074B1 (en) 2017-06-30 2017-06-30 A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium

Country Status (1)

Country Link
KR (1) KR102133074B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102632084B1 (en) 2020-12-10 2024-02-02 (주)다럼앤바이오 Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000019981A (en) 1998-09-17 2000-04-15 안용찬 Skin preparation containing extract of bamboosae calulis in taeniam for external use
KR20020003313A (en) 2000-10-20 2002-01-12 주식회사 바이오리 Skin external preparation containing pine pollen or pine pollen extract
KR20020073041A (en) * 2001-03-14 2002-09-19 주식회사 에스티씨나라 Composition of natural material for acne treatment and prevention
KR20030016818A (en) 2001-08-22 2003-03-03 애경산업(주) Cosmetic compositons for acne skin containing natural fragrant oil
KR20040081533A (en) 2003-03-13 2004-09-22 한국콜마 주식회사 Cosmetic product & its manufacturing methods containing essential oil of Citrus unshiu fruit, which has antibacterial activity against acne-causing bacterium
KR100700911B1 (en) 2005-12-30 2007-03-28 고려대학교 산학협력단 Acidic polysaccharide extracted from ginseng root and its composition for preventing human cellular interaction of Propionibacterium acnes and Staphylococcus aureus
KR100700912B1 (en) 2005-12-30 2007-03-28 고려대학교 산학협력단 Human Cell Binding Inhibitory Activity of Acne Bacillus and Atopic Staphylococcus aureus Containing Acidic Polysaccharides Isolated from Green Tea Leaves
KR20070110589A (en) 2006-05-15 2007-11-20 고려대학교 산학협력단 Acidic polysaccharide extracted from mugwort and its composition for the use of preventing human cellular interaction of propionibacterium acnes and staphylococcus aureus
KR20080044948A (en) 2006-11-17 2008-05-22 주식회사 휴온스 Method for extraction and purification of effective component from agrimonia pilosa ledeb and crude drug composition containing extract thereof for prevention and treatment of pimple
KR20090117199A (en) 2008-05-09 2009-11-12 (주)더페이스샵코리아 The cosmetic composion containing the extracts of sanguisorba officinalis
KR20120086123A (en) 2011-01-25 2012-08-02 재단법인 제주테크노파크 External Composition for Skin Having Antibacterial Activities
KR20130113018A (en) 2012-04-05 2013-10-15 이진태 Development of a mouthwash using sanguisoba officinalis for breaking down plaque
CN103372076A (en) * 2012-04-20 2013-10-30 北京北大维信生物科技有限公司 Medicine for treating diseases caused by propionibacterium acnes and application of sanguisorba officinalis and/or sanguisorba officinalis extract
KR20140099223A (en) 2014-07-17 2014-08-11 (주)제주사랑농수산 Antimicrobial Composition Using an Plant Extract
KR20150000723A (en) 2013-06-25 2015-01-05 한국콜마주식회사 A Cosmetic Composition Containing Extracts of Potentilla kleiniana Wight et Arnott Having antibacterial Activity
KR101507889B1 (en) 2014-11-04 2015-04-07 한국콜마주식회사 COSMETIC COMPOSITION CONTAINING EXTRACT FROM Callistemon lanceola HAVING ANTI-ACNE MICROBE ACTIVITY
KR20160102638A (en) 2015-02-23 2016-08-31 한림대학교 산학협력단 Composition for treating diabete and diabete-induced complication containing an extract from Sanguisorba officinalis L.
KR20160150177A (en) 2015-06-18 2016-12-29 전남대학교산학협력단 Anti-Viral Compositions against Fish Pathogenic Virus comprising Extract or Fractions from Sanguisorba officinlis as Active Ingredient
KR20170055104A (en) 2015-11-11 2017-05-19 전북대학교산학협력단 Composition for preventing or treating sepsis comprising Sanguisorba officinalis extract as effective component

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000019981A (en) 1998-09-17 2000-04-15 안용찬 Skin preparation containing extract of bamboosae calulis in taeniam for external use
KR20020003313A (en) 2000-10-20 2002-01-12 주식회사 바이오리 Skin external preparation containing pine pollen or pine pollen extract
KR20020073041A (en) * 2001-03-14 2002-09-19 주식회사 에스티씨나라 Composition of natural material for acne treatment and prevention
KR20030016818A (en) 2001-08-22 2003-03-03 애경산업(주) Cosmetic compositons for acne skin containing natural fragrant oil
KR20040081533A (en) 2003-03-13 2004-09-22 한국콜마 주식회사 Cosmetic product & its manufacturing methods containing essential oil of Citrus unshiu fruit, which has antibacterial activity against acne-causing bacterium
KR100700911B1 (en) 2005-12-30 2007-03-28 고려대학교 산학협력단 Acidic polysaccharide extracted from ginseng root and its composition for preventing human cellular interaction of Propionibacterium acnes and Staphylococcus aureus
KR100700912B1 (en) 2005-12-30 2007-03-28 고려대학교 산학협력단 Human Cell Binding Inhibitory Activity of Acne Bacillus and Atopic Staphylococcus aureus Containing Acidic Polysaccharides Isolated from Green Tea Leaves
KR20070110589A (en) 2006-05-15 2007-11-20 고려대학교 산학협력단 Acidic polysaccharide extracted from mugwort and its composition for the use of preventing human cellular interaction of propionibacterium acnes and staphylococcus aureus
KR20080044948A (en) 2006-11-17 2008-05-22 주식회사 휴온스 Method for extraction and purification of effective component from agrimonia pilosa ledeb and crude drug composition containing extract thereof for prevention and treatment of pimple
KR20090117199A (en) 2008-05-09 2009-11-12 (주)더페이스샵코리아 The cosmetic composion containing the extracts of sanguisorba officinalis
KR20120086123A (en) 2011-01-25 2012-08-02 재단법인 제주테크노파크 External Composition for Skin Having Antibacterial Activities
KR20130113018A (en) 2012-04-05 2013-10-15 이진태 Development of a mouthwash using sanguisoba officinalis for breaking down plaque
CN103372076A (en) * 2012-04-20 2013-10-30 北京北大维信生物科技有限公司 Medicine for treating diseases caused by propionibacterium acnes and application of sanguisorba officinalis and/or sanguisorba officinalis extract
KR20150000723A (en) 2013-06-25 2015-01-05 한국콜마주식회사 A Cosmetic Composition Containing Extracts of Potentilla kleiniana Wight et Arnott Having antibacterial Activity
KR20140099223A (en) 2014-07-17 2014-08-11 (주)제주사랑농수산 Antimicrobial Composition Using an Plant Extract
KR101507889B1 (en) 2014-11-04 2015-04-07 한국콜마주식회사 COSMETIC COMPOSITION CONTAINING EXTRACT FROM Callistemon lanceola HAVING ANTI-ACNE MICROBE ACTIVITY
KR20160102638A (en) 2015-02-23 2016-08-31 한림대학교 산학협력단 Composition for treating diabete and diabete-induced complication containing an extract from Sanguisorba officinalis L.
KR20160150177A (en) 2015-06-18 2016-12-29 전남대학교산학협력단 Anti-Viral Compositions against Fish Pathogenic Virus comprising Extract or Fractions from Sanguisorba officinlis as Active Ingredient
KR20170055104A (en) 2015-11-11 2017-05-19 전북대학교산학협력단 Composition for preventing or treating sepsis comprising Sanguisorba officinalis extract as effective component

Non-Patent Citations (27)

* Cited by examiner, † Cited by third party
Title
An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 131-145
An et al., Kor. J. Kor. Soc. Appl. Biol. Chem. 2004, Vol. 47, pp. 244-250
Ban et al., Kor. J. Med. Crop Sci. 2005, Vol. 13, pp. 219-226
Chomnawang et al., Fitoterapia 2007, Vol. 78, pp. 401-408
Goun et al., J. Ethnopharm. 2002, Vol. 81, pp. 337-342
Hwang et al., J. Physiol. Pathol. Kor. Med. 2014, Vol. 28, pp. 499-505
Kim et al., J. Microbial. Biotechnol. 2010, Vol. 20, pp. 82-87
Kim et al., Kor. J. Food Cook. Sci. 2011, Vol. 27, pp. 15-26
Kim et al., Nat. Prod. Sci. 2002, Vol. 8, pp. 177-182
Kumar et al., Trop. J. Pharm. Res. 2007, Vol. 6, pp. 717-723
Lee et al., J. Korean Soc. Food Sci. Nutr. 2005, Vol. 34, pp. 1545-1552
Lim et al., J. Microbiol. 2007, Vol. 45, pp. 473-477
Muddathir et al., J. Woos Sci. 2013, Vol. 59, pp. 426-431
Park et al., Kor. J. Herb. 2012, Vol. 27, pp. 23-29
Park et al., Korean J. Food Preserv. 2012, Vol. 19, pp 744-750
Pothitirat et al., Med. Princ. Pracy. 2010, Vol. 19, pp. 281-286
Pothitirat et al., Pharm. Biol. 2010, Vol. 48, pp. 182-186
Qidwai et al., Int. J. Pharm. Sci. Res. 2016, Vol. 7, pp. 2917-2924
Sathishkumar et al., J. Photocheml. PhotoBiol., B: Biology 2010, Vol. 20, pp. 82-87
Shah et al., J. Med. Plants Res. 2015, Vol. 9, pp. 755-763
Sharma and Lall, S. Afr. J. Sci. 2014, Vol. 110, Aer. # 2013-0293
Sharma et al., Phytother. Res. 2011, Vol. 25, pp. 517-521
Son et al., J. Kor. Acad. Oral Health 2015, Vol. 28, pp. 97-104
Tangje Arung et al., Biodiversitas 2017, Vol. 18, pp. 321-325
Tsai et al., Food Chem. 2010, Vol. 119, pp. 964-968
Vijayalakshimi et al., Int. J. PharmTech Res. 2011, Vol. 3, pp. 320-327
Wang et al., J. Agric. Food Chem. 2013, Vol. 61, pp. 12274-12282

Also Published As

Publication number Publication date
KR102133074B1 (en) 2020-07-10

Similar Documents

Publication Publication Date Title
KR102234568B1 (en) Cosmetic composition for improving skin inflammation comprising fermentated extract of inula britannica flowers and method for prparing thereof
Silva et al. Hypericum genus cosmeceutical application–A decade comprehensive review on its multifunctional biological properties
KR20210018735A (en) Compositions for Anti-Acne and Anti-Inflammatory Effect Comprising Complex Extract of Houttuynia cordata
KR20200122304A (en) Kapok tree flower extract, and cosmetic, pharmaceutical or dermatological composition containing the same
KR102065185B1 (en) Composition for Improving Skin Conditions with Improved Anti-Bacterial, Anti-inflammatory, Anti-wrinkling, and Skin Whitening Property
KR102059392B1 (en) Antimicrobial and Antifungal Composition Containing Clove, Hibiscus, and Coconut Extract Complex as Active Ingredient
KR20240004199A (en) Antibacterial composition containing extract or fractions of Prunus pendula for. ascendens
KR101676503B1 (en) A topical composition comprising extracts of a. indica and m. charantia or s. indicum
KR102133074B1 (en) A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium
KR102145297B1 (en) Antiinflammatory and antibaterial compositions comprising extract of artemisiae annuae herb, ginkgo biloba and ficuscarica l.
KR102367027B1 (en) Antimicrobial composition comprising Hydrangea petiolaris extracts or fractions thereof as effective component
KR102214505B1 (en) Skin External Preparation and Cosmetic Compositions Comprising Extract of Viburnum erosum Thunb.
KR102132514B1 (en) A cosmetic composition containing hot water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium
KR20190079875A (en) An anti-microbial compositions comprising Abeliophyllum distichum extract as an active ingredient
KR20170099762A (en) Composition for improving acne containing kaempferia parviflora
KR102009604B1 (en) Antimicrobial composition comprising lonicera japonica extract and magnolia obovata extract
KR100993676B1 (en) Composition for prevention or treatment of Acne
KR101253279B1 (en) Anti-Bacterial Composition Comprising Extract from Leaf of Ilex rotunda or Phenylpropanoid Compound As Active Ingredient
KR101921050B1 (en) An antimicrobial composition for improving acne comprising plant-derived natural compounds
KR20100079825A (en) Antibiotic composition containing lily extract and preparation method of the same
KR20190003014A (en) A cosmetic composition containing methanol extract or its raction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium
KR20160062235A (en) Cosmetic composition for whitening skin comprising mixed extract of Cudrania tricuspidata leaf and Morus alba leaf as effective component
KR102359223B1 (en) Cosmetic composition comprising mangifera indica irwin seed extract
KR102316110B1 (en) Functional cosmetic composition comprising complex extract of walnut shell and persimmon calyx as effective ingredient, and manufacturing method thereof
KR102379678B1 (en) Antibacterial composition containing extract or fractions of fermented black radish

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant